Arcutis Biotherapeutics, Inc. (ARQT) SEC Filings & Financial Intelligence
Arcutis Biotherapeutics, Inc. (ARQT) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ARQT
CIK: 1787306
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2018 12:00:00 AM
Lead Engagement PartnerMark Montoya
Audit LocationLos Angeles, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-11-04 | 2026-11-02 | FORM 4 | 0001628280-26-070385 | View SEC Doc Filr Page |
| 3 | 2026-11-04 | 2026-11-04 | FORM 3 | 0001628280-26-070384 | View SEC Doc Filr Page |
| 4 | 2026-11-04 | 2026-11-02 | FORM 4 | 0001628280-26-070383 | View SEC Doc Filr Page |
| 3/A | 2026-11-04 | 2026-10-23 | FORM 3/A | 0001628280-26-070382 | View SEC Doc Filr Page |
| 4 | 2026-11-04 | 2026-11-02 | FORM 4 | 0001628280-26-070381 | View SEC Doc Filr Page |
| 144 | 2026-11-04 | — | 144 Filing | 0001628280-26-070283 | View SEC Doc Filr Page |
| 424B5 | 2026-11-04 | — | 424B5 | 0001628280-26-070167 | View SEC Doc Filr Page |
| 10-Q | 2026-11-04 | 2026-09-30 | 10-Q | 0001787306-26-000057 | View SEC Doc Filr Page |
| 8-K | 2026-11-04 | 2026-11-04 | 8-K | 0001787306-26-000056 | View SEC Doc Filr Page |
| 144 | 2026-11-02 | — | 144 Filing | 0001628280-26-068988 | View SEC Doc Filr Page |
| 144 | 2026-11-02 | — | 144 Filing | 0001628280-26-068986 | View SEC Doc Filr Page |
| 144 | 2026-11-02 | — | 144 Filing | 0001628280-26-068984 | View SEC Doc Filr Page |
| 3 | 2026-10-28 | 2026-10-23 | FORM 3 | 0001628280-26-067900 | View SEC Doc Filr Page |
| 4 | 2026-10-28 | 2026-10-23 | FORM 4 | 0001628280-26-067898 | View SEC Doc Filr Page |
| 8-K | 2026-10-28 | 2026-10-23 | 8-K | 0001628280-26-067752 | View SEC Doc Filr Page |
| 144 | 2026-10-20 | — | 144 Filing | 0001628280-26-066520 | View SEC Doc Filr Page |
| 4 | 2026-10-19 | 2026-10-15 | FORM 4 | 0001628280-26-066331 | View SEC Doc Filr Page |
| 144 | 2026-10-15 | — | 144 Filing | 0001628280-26-065989 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-10-05 | — | SCHEDULE 13G/A Filing | 0002012383-26-003314 | View SEC Doc Filr Page |
| 4 | 2026-09-18 | 2026-09-16 | FORM 4 | 0001628280-26-062732 | View SEC Doc Filr Page |
| 4 | 2026-09-17 | 2026-09-15 | FORM 4 | 0001628280-26-062490 | View SEC Doc Filr Page |
| 144 | 2026-09-16 | — | 144 Filing | 0001628280-26-062242 | View SEC Doc Filr Page |
| 144 | 2026-09-15 | — | 144 Filing | 0001628280-26-062042 | View SEC Doc Filr Page |
| 4 | 2026-09-10 | 2026-09-08 | FORM 4 | 0001628280-26-061444 | View SEC Doc Filr Page |
| 144 | 2026-09-08 | — | 144 Filing | 0001628280-26-060930 | View SEC Doc Filr Page |